ArticleEMBO molecular medicine2023

RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.

Marina Ciscar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.